SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Kalayoglu M.V., Libby P., Byrne G.I. (2002) Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA 288: 272431.
  • 2
    Pollmann M., Nordhoff M., Pospischil A., Tedin K., Wieler L.H. (2005) Effects of a probiotic strain of Enterococcus faecium on the rate of natural Chlamydia infection in Swine. Infect Immun 73: 434653.
  • 3
    Saikku P., Leinonen M., Mattila K. J., Ekman M.R., Nieminen MS, Mäkelä P.H. et al. (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 8618: 9836.
  • 4
    Thomas G.N., Scheel O., Koehler A.P., Bassett D.C.J., Cheng A.F.B. (1997) Respiratory chlamydial infections in a Hong Kong teaching hospital and association with coronary heart disease. Scand J Infect Dis 104(Suppl): 303.
  • 5
    Romano Carratelli C., Nuzzo I., Cozzolino D., Bentivoglio C., Paolillo R., Rizzo A. (2006) Relationship between Chlamydia pneumoniae infection, inflammatory markers, and coronary heart diseases. Int Immunopharmacol 6: 84853.
  • 6
    Meurman J.H., Sanz M., Janket S.J. (2004) Oral health, atherosclerosis, and cardiovascular disease. Crit Rev Oral Biol Med 15: 40313.
  • 7
    Leinonen M., Saikku P. (2000) Infections and atherosclerosis. Scand Cardiovasc J 34: 1220.
  • 8
    Taylor-Robinson D., Aduse-Opoku J., Sayed P., Slaney J.M., Thomas B.J., Curtis M.A. (2002) Oro-dental bacteria in various atherosclerotic arteries. Eur J Clin Microbiol Infect Dis 21: 7557.
  • 9
    Mäntylä P., Stenman M., Paldanius M., Saikku P., Sorsa T., Meurman J.H. (2004) Chlamydia pneumoniae together with collagenase-2 (MMP-8) in periodontal lesions. Oral Dis 10: 325.
  • 10
    Reed S.G., Lopatin D.E., Foxman B., Burt B.A. (2000) Oral Chlamydia trachomatis in patients with established periodontitis. Clin Oral Invest 4: 22632.
  • 11
    Loos B.G., Craandijk J., Hoek F.J., Wertheim-van Dillen P.M., Van Der Velden U. (2000) Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 71: 152834.
  • 12
    Haraszthy V.I., Zambon J.J., Trevisan M., Zeid M., Genco R.J. (2000) Identification of periodontal pathogens in atheromatous plaques. J Periodontol 71: 155460.
  • 13
    Ford P.J., Gemmell E., Chan A., Carter C.L., Walker P.J., Bird P.S. et al. (2006) Inflammation, heat shock proteins and periodontal pathogens in atherosclerosis: an immunohistologic study. Oral Microbiol Immunol 21: 20611.
  • 14
    Haffajee A.D., Socransky S.S. (1994) Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 5: 78111.
  • 15
    Carranza F.A. (1984) Glickman's Clinical Periodontology. Philadelphia : Saunders.
  • 16
    Dongari-Bagtzoglou A., Emersole J.L. (1996) Production of inflammatory mediators and cytokines by human gingival fibroblasts following bacterial challenge. J Periodontal Res 31: 908.
  • 17
    Imatani T., Kato T., Okuda K. (2001) Production of inflammatory cytokines by human gingival fibroblasts stimulated by cell-surface preparations of Porphyromonas gingivalis. Oral Microbiol Immunol 16: 6572.
  • 18
    Roblin P.M., Dumornay W., Hammerschlang M.R. (1992) Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol 30: 196871.
  • 19
    Coombes B.K., Mahony J.B. (1999) Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s). Infect Immun 67: 290915.
  • 20
    Molestina R.E., Miller R.D., Ramirez J.A., Summersgil J.T. (1999) Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes. Infect Immun 67: 132330.
  • 21
    Hirono S., Dibrov E., Hurtado C., Kostenuk A., Ducas R., Pierce G.N. (2003) Chlamydia pneumoniae stimulates proliferation of vascular smooth muscle cells through induction of endogenous heat shock protein 60. Circ Res 93: 7106.
  • 22
    Cornelsen Gencay M.M., Tamm M., Glanville A., Perruchoud A.P., Roth M. (2003) Chlamydia pneumoniae activates epithelial cell proliferation via NF-κB and the glucocorticoid receptor. Infect Immun 71: 581422.
  • 23
    Dolfini E., Elli L., Roncoroni L., Costa B., Colleoni M.P., Lorusso V. et al. (2005) Damaging effects of gliadin on three-dimensional cell culture model. World J Gastroenterol 11: 59737.
  • 24
    Gervassi A., Alderson M.R., Suchland R., Maisonneuve J.F., Grabstein K.H., Probst P. (2004) Differential regulation of inflammatory cytokine secretion by human dendritic cells upon Chlamydia trachomatis infection. Infect Immun 72: 72319.
  • 25
    Gerard H.C., Wang Z., Whittum-Hudson J.A., El-Gabalawy H., Goldbach-Mansky R., Bardin T. et al. (2002) Cytokine and chemokine mRNA produced in synovial tissue chronically infected with Chlamydia trachomatis and C. pneumoniae. J Rheumatol 29: 182735.
  • 26
    Kol A., Sokova G.K., Lichtman A.H., Libby P. (1998) Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 98: 3007.
  • 27
    Redecke V., Dalhoff K., Bohnet S., Braun J., Maass M. (1998) Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response. Am J Respir Cell Mol Biol 19: 7217.
  • 28
    Rottenberg ME, Gigliotti Rothfuchs A, Gigliotti D, Ceausu M, Une C, Levitsky V et al. (2000) Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae. J Immunol 164: 481218.
  • 29
    Rottenberg M.E., Gigliotti-Rothfuchs A., Wigzell H. (2002) The role of IFN-gamma in the outcome of chlamydial infection. Curr Opin Immunol 14: 44451.
  • 30
    Dorn B.R., Dunn W.A., Progulske-Fox A. (1999) Invasion of human coronary artery cells by periodontal pathogens. Infect Immun 67: 57925798.
  • 31
    Garlet G.P., Cardoso C.R., Silva T.A., Ferreira B.R., Ávila-Campos M.J. (2006) Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMps, RANKL, and their physiological inhibitors. Oral Microbiol Immunol 21: 1220.
  • 32
    Hirano T., Akira S., Taga T, Kishimoto T. (1990) Biological and clinical aspects of interleukin-6. Immunol Today 11: 4439.
  • 33
    Sporn M.B., Roberts A.B. (1988) Peptide growth factors are multifunctional. Nature 332: 2179.
  • 34
    Yushi U., Hideki S., Hitoshi K., Toshinobu T., Masatoshi S., Tsuyoshi F. et al. (2001) Expression of IL-1β and IL-8 by human gingival epithelial cells in response to Actinobacillus actinomycetemcomitans. Cytokine 14: 15261.
  • 35
    Wang H., Eckels D.D. (1999) Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition. J Immunol 162: 417783.
  • 36
    Sher A., Fiorentino D., Caspar P., Pearce E., Mosmann T. 1991 Production of IL-10 by CD4+ T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. J Immunol 147: 271316.
  • 37
    Blauer F., Groscurth P., Schneemann M., Schoedon G., Schaffner A. (1995) Modulation of the antilisterial activity of human blood-derived macrophages by activating and deactivating cytokines. J Interferon Cytokine Res 15: 10514.
  • 38
    Caspar-Bauguil S., Puissant B., Nazzal D., Lefèvre J.C., Thomsen M., Salvayre R. et al. (2000) Chlamydia pneumoniae induces interleukin-10 production that down-regulates major histocompatibility complex Class I expression. J Infect Dis 182: 1394401.
  • 39
    Haralambieva I., Iankov I., Mitev V., Mitov I. (2002) KN-62 enhances Chlamydia pneumoniae-induced p44/p42 mitogen-activated protein kinase activation in murine fibroblasts and attenuates in vitro infection. FEMS Microbiol Lett 215: 14955.
  • 40
    Chang L., Karin M. (2001) Mammalian MAP kinase signaling cascades. Nature 410: 3740.
  • 41
    Miller S.A., Selzman C.H., Shames B.D., Barton H.A., Johnson S.M., Harken H. (2000) Chlamydia pneumoniae activates nuclear factor β and activator protein 1 in human vascular smooth muscle and induces cellular proliferation. J Surg Res 90:7681.
  • 42
    Sasu S., La Verda D., Qureshi N., Golenbock D.T., Beasley D. (2001) Chlamydia pneumoniae and Chlamydial Heat Shock Protein 60 stimulate proliferation of human vascular smooth muscle cells via Toll-Like Receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circ Res 89: 24450.
  • 43
    Cho Y.S., Kim T.-B., Lee T.-H., Moon K.-A., Lee J., Kimw Y.-K. et al. (2005) Chlamydia pneumoniae infection enhances cellular proliferation and reduces steroid responsiveness of human peripheral blood mononuclear cells via a tumor necrosis factor-α-dependent pathway. Clin Exp Allergy 35: 162531.
  • 44
    Kent L.W., Rahemtulla F., Hockett R.D., Gilleland R.C., Michalek S.M. (1998) Effect of lipopolysaccharide and inflammatory cytokines on interleukin-6 production by healthy human gingival fibroblasts. Infect Immun 66: 60814.
  • 45
    Nowak R., Oelschlägel U., Gurth H., Range U., Albrecht S., Krebs U. et al. (1999) Relations between IL-3-induced proliferation and in vitro cytokine secretion of bone marrow cells from AML patients. Cytokine 11: 43542.
  • 46
    Haralambieva I.H., Iankov I.D., Iavanova P.V., Mitev V., Mitov I.G. (2004) Chlamydophila pneumoniae induces p44/p42 mitogen-activated protein kinase activation in human fibroblasts through Toll-like receptor 4. J Med Microbiol 53: 118793.
  • 47
    Netea M.G., Kullberg B.J., Galama J.M.D., Stalenhoef A.F.H., Dinarello C.A., Van Der Meer J.W.M. (2002) Non-LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-Like receptor 2-dependent pathways. Eur J Immunol 32: 118895.
  • 48
    Molestina R.E., Dean D., Miller R.D., Ramirez J.A., Summersgill J.T. (1998) Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells. Infect Immun 66: 13706.
  • 49
    Means T.K., Golenbock D.T., Fenton M.J. (2000) Structure and function of toll-like receptor proteins. Life Sci 68: 24158.
  • 50
    Means T.K., Golenbock D.T., Fenton M.J. (2000) The biology of Toll-like receptors. Cytokine Growth Factor Rev 11: 21932.
  • 51
    Underhill D.M., Ozynsky A. (2002) Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol 14: 10310.
  • 52
    Netea M.G., Selzman C.H., Kullberg B.J., Galama J.M.D., Weinberg A., Stalenhoef A.F.H. et al. (2000) Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells. Eur J Immunol 30: 5419.
  • 53
    Yang J., Hooper W.C., Phillips D.J., Tondella M.L., Talkington D.F. (2003) Induction of proinflammatory cytokines in human lung epithelial cells during Chlamydia pneumoniae infection. Infect Immun 71: 61420.